Chimerix (CMRX) Tops Q4 EPS by 10c; Issues Updat on Phase 3 SUPPRESS

March 7, 2014 8:23 AM

Chimerix (NASDAQ: CMRX) reported Q4 EPS of ($0.31), $0.10 better than the analyst estimate of ($0.41). Revenue for the quarter ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found